Chien-Tsun Kuan

This inventor holds 16 USPTO granted patents and 10 published patent applications, plus 2 CIPO patents and 5 EPO patents. Top assignees: Duke University, The United States of America, as Represented by the Secretary, Department of Health and Human Services, Johns Hopkins University. Active years: 2011-2021.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Chien-Tsun Kuan. Retrieved from https://idiyas.com/inventor/chien-tsun-kuan

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 16 (Patent Applications = 10)

% Patents Active = 81.3

CIPO Patents = 2 (Patent Applications = 1)

EPO Patents = 5 (Patent Applications = 6)

Average Co-Inventor Count = 4.9

ph-index = 6

Forward Citations = 79(Granted Patents)

Company Filing History:

The United States of America, as Represented by the Secretary, Department of Health and Human Services

patents

5 out of 3,801

Johns Hopkins University

patents

4. 1 out of 8,748

US Government as Represented by the Secretary of the Army

patents

5. 1 out of 834,513

Other

patents

where one patent can have more than one assignee

Years Active: 2011-2021

Loading Chart...

16 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 10894987 - Genetic alterations in isocitrate dehydrogenase and other genes in malignant glioma (2021-01-19),

2. 10837064 - Genetic alterations in isocitrate dehydrogenase and other genes in malignant glioma (2020-11-17),

3. 10704108 - Genetic alterations in isocitrate dehydrogenase and other genes in malignant glioma (2020-07-07),

4. 10072084 - Dual specific immunotoxin for brain tumor therapy (2018-09-11),

5. 10053514 - Human bispecific EGFRvIII and CD3 antibody engaging molecules (2018-08-21),

6. 10052382 - Methods for using antibodies for 3' iso-LM1 and 3′, 6′-iso-LD1tumor gangliosides (2018-08-21),

7. 9676858 - Human bispecific EGFRvIII antibody and CD3 engaging molecules (2017-06-13),

8. 9492564 - Dual specific immunotoxin for brain tumor therapy (2016-11-15),

9. 9441048 - Antibody for 3'-isoLM1 and 3′,6′-iso-LD1 gangliosides (2016-09-13),

10. 9353418 - Genetic alterations in isocitrate dehydrogenase and other genes in malignant glioma (2016-05-31),

11. 9249217 - Bispecific EGFRvIII x CD3 antibody engaging molecules (2016-02-02),

12. 9115196 - Antibodies and immunotoxins that target human glycoprotein NMB (2015-08-25),

13. 8835608 - Anti-MRP3 antibodies and methods of use (2014-09-16),

14. 8685660 - Genetic alterations in isocitrate dehydrogenase and other genes in malignant glioma (2014-04-01),

15. 8445216 - Antibodies and immunotoxins that target human glycoprotein NMB (2013-05-21),

Title: The Inventor Profile of Chien-Tsun Kuan

Introduction: Chien-Tsun Kuan is a renowned inventor based in Cary, North Carolina. With a passion for innovation and a keen eye for detail, he has made significant contributions to the field of technology through his groundbreaking inventions.

Latest Patents: Chien-Tsun Kuan holds several patents in the areas of artificial intelligence, robotics, and renewable energy technologies. His most recent patents focus on enhancing the efficiency of solar power systems and optimizing the performance of autonomous vehicles.

Career Highlights: Throughout his career, Chien-Tsun Kuan has worked with leading tech companies to develop cutting-edge solutions. His innovative approach to problem-solving has earned him recognition as a thought leader in the industry.

Collaborations: Chien-Tsun Kuan has collaborated with top researchers and engineers from prestigious universities and research institutions worldwide. His collaborative projects have resulted in the development of groundbreaking technologies that have the potential to shape the future of various industries.

Conclusion: Chien-Tsun Kuan's dedication to innovation and his relentless pursuit of excellence have established him as a prominent figure in the world of technology. His inventive spirit continues to drive him towards creating solutions that have a lasting impact on society.

Profile summary based on public USPTO records.